Back
Galectin Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
GALT
Galectin Therapeutics
Last Price:
2.77
Seasonality Move:
36.71%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GALT is experiencing slight buying pressure.
Galectin Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.77 | Buy |
| 20-day SMA: | 2.72 | Buy |
| 50-day SMA: | 2.7 | Buy |
| 200-day SMA: | 2.6 | Buy |
| 8-day EMA: | 2.77 | Buy |
| 20-day EMA: | 2.74 | Buy |
| 50-day EMA: | 2.68 | Buy |
| 200-day EMA: | 2.51 | Buy |
Galectin Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 53.13 | Buy |
| Chaikin Money Flow: | 57181 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.53 - 2.85) | Buy |
| Bollinger Bands (100): | (2.33 - 2.77) | Buy |
Galectin Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Galectin Therapeutics Stock
Is Galectin Therapeutics Stock a Buy?
- Galectin Therapeutics share price is 2.78 while GALT 8-day simple moving average is 2.77, which is a Buy signal.
- The stock price of GALT is 2.78 while Galectin Therapeutics 20-day SMA is 2.72, which makes it a Buy.
- Galectin Therapeutics 50-day simple moving average is 2.70 while GALT share price is 2.78, making it a Buy technically.
- GALT stock price is 2.78 and Galectin Therapeutics 200-day simple moving average is 2.60, creating a Buy signal.
GALT Technical Analysis vs Fundamental Analysis
Sell
46
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy or a Sell?
-
Galectin Therapeutics stock is rated a Sell
The current Galectin Therapeutics [GALT] share price is $2.78. The Score for GALT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Galectin Therapeutics Stock Info
Market Cap:
174.48M
Price in USD:
2.78
Share Volume:
133.42K
Galectin Therapeutics 52-Week Range
52-Week High:
4.27
52-Week Low:
1.56
Sell
46
Galectin Therapeutics (GALT)
is a Sell
Galectin Therapeutics Share Price Forecast
-
What is the Galectin Therapeutics stock price today?
The Galectin Therapeutics stock price is 2.78 USD today. -
Will GALT stock go up or go down?
Galectin Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Galectin Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Galectin Therapeutics is overvalued.
Is Galectin Therapeutics Stock a Buy?
- Galectin Therapeutics share price is 2.78 while GALT 8-day exponential moving average is 2.77, which is a Buy signal.
- The stock price of GALT is 2.78 while Galectin Therapeutics 20-day EMA is 2.74, which makes it a Buy.
- Galectin Therapeutics 50-day exponential moving average is 2.68 while GALT share price is 2.78, making it a Buy technically.
- GALT stock price is 2.78 and Galectin Therapeutics 200-day simple moving average is 2.51, creating a Buy signal.
Technical Analysis of Galectin Therapeutics
Should I short Galectin Therapeutics stock?
- GALT Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Galectin Therapeutics is a Buy
- Galectin Therapeutics Relative Strength Index (RSI) is 53.13, which suggest Galectin Therapeutics is overbought
- The Bollinger Bands (25) for Galectin Therapeutics is (2.53 - 2.85), which suggest Galectin Therapeutics is a Buy
- The Bollinger Bands (100) for Galectin Therapeutics is (2.33 - 2.77), which suggest Galectin Therapeutics is a Buy
* Galectin Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.